Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vericel Corp (NASDAQ:VCEL)

2.85
Delayed Data
As of Mar 24
 +0.05 / +1.79%
Today’s Change
1.96
Today|||52-Week Range
6.69
-5.00%
Year-to-Date

Today’s Trading

Previous close2.80
Today’s open2.75
Day’s range2.70 - 2.85
Volume215,716
Average volume (3 months)1,389,232
Market cap$93.3M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-21.65%
Earnings growth (this year)+50.28%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+6.28%
P/E ratioNM
Price/Sales1.27
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ECYTEndocyte Inc-0.04-1.78%
ADMPAdamis Pharmaceutica...+0.10+2.38%
ALIMAlimera Sciences Inc+0.03+2.08%
BDSIBioDelivery Sciences...-0.18-9.09%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$54.4M
Annual profit (last year)-$19.6M
Net profit margin-35.98%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs